Assessing the Human Canonical Protein Count[Version 1; Peer Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Coding Exons Function As Tissue-Specific Enhancers of Nearby Genes
Downloaded from genome.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Research Coding exons function as tissue-specific enhancers of nearby genes Ramon Y. Birnbaum,1,2 E. Josephine Clowney,3,4 Orly Agamy,5 Mee J. Kim,1,2 Jingjing Zhao,1,2,6 Takayuki Yamanaka,1,2 Zachary Pappalardo,1,2 Shoa L. Clarke,7 Aaron M. Wenger,8 Loan Nguyen,1,2 Fiorella Gurrieri,9 David B. Everman,10 Charles E. Schwartz,10,11 Ohad S. Birk,5 Gill Bejerano,8,12 Stavros Lomvardas,3 and Nadav Ahituv1,2,13 1Department of Bioengineering and Therapeutic Sciences, 2Institute for Human Genetics, 3Department of Anatomy, 4Program in Biomedical Sciences, University of California, San Francisco, California 94143, USA; 5The Morris Kahn Laboratory of Human Genetics, NIBN, Ben-Gurion University, Beer-Sheva 84105, Israel; 6Key Laboratory of Advanced Control and Optimization for Chemical Processes of the Ministry of Education, East China University of Science and Technology, Shanghai 200237, China; 7Department of Genetics, 8Department of Computer Science, Stanford University, Stanford, California 94305-5329, USA; 9Istituto di Genetica Medica, Universita` Cattolica S. Cuore, Rome 00168, Italy; 10JC Self Research Institute, Greenwood Genetic Center, Greenwood, South Carolina 29646, USA; 11Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina 29634, USA; 12Department of Developmental Biology, Stanford University, Stanford, California 94305-5329, USA Enhancers are essential gene regulatory elements whose alteration can lead to morphological differences between species, developmental abnormalities, and human disease. Current strategies to identify enhancers focus primarily on noncoding se- quences and tend to exclude protein coding sequences. -
Transcriptome Analyses of Rhesus Monkey Pre-Implantation Embryos Reveal A
Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Transcriptome analyses of rhesus monkey pre-implantation embryos reveal a reduced capacity for DNA double strand break (DSB) repair in primate oocytes and early embryos Xinyi Wang 1,3,4,5*, Denghui Liu 2,4*, Dajian He 1,3,4,5, Shengbao Suo 2,4, Xian Xia 2,4, Xiechao He1,3,6, Jing-Dong J. Han2#, Ping Zheng1,3,6# Running title: reduced DNA DSB repair in monkey early embryos Affiliations: 1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China 2 Key Laboratory of Computational Biology, CAS Center for Excellence in Molecular Cell Science, Collaborative Innovation Center for Genetics and Developmental Biology, Chinese Academy of Sciences-Max Planck Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China 3 Yunnan Key Laboratory of Animal Reproduction, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China 4 University of Chinese Academy of Sciences, Beijing, China 5 Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan 650204, China 6 Primate Research Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China * Xinyi Wang and Denghui Liu contributed equally to this work 1 Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press # Correspondence: Jing-Dong J. Han, Email: [email protected]; Ping Zheng, Email: [email protected] Key words: rhesus monkey, pre-implantation embryo, DNA damage 2 Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press ABSTRACT Pre-implantation embryogenesis encompasses several critical events including genome reprogramming, zygotic genome activation (ZGA) and cell fate commitment. -
3De8d416-B844-4E9a-B3fb-A2e883a4083f 11119
Edinburgh Research Explorer Last rolls of the yoyo: Assessing the human canonical protein count Citation for published version: Southan, C 2017, 'Last rolls of the yoyo: Assessing the human canonical protein count', F1000Research, vol. 6, pp. 448+. https://doi.org/10.12688/f1000research.11119.1 Digital Object Identifier (DOI): 10.12688/f1000research.11119.1 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: F1000Research Publisher Rights Statement: This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication). General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately -
Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen, -
Genome-Wide Profiling of P63 DNA-Binding Sites Identifies an Element That Regulates Gene Expression During Limb Development in the 7Q21 SHFM1 Locus
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/88501 Please be advised that this information was generated on 2021-10-07 and may be subject to change. OPEN 3 ACCESS Freely available online PIPS GENETICS Genome-Wide Profiling of p63 DNA-Binding Sites Identifies an Element that Regulates Gene Expression during Limb Development in the 7q21 SHFM1 Locus Evelyn N. Kouwenhoven1®, Simon J. van Heeringen2®, Juan J. Tena3®, Martin Oti4, Bas E. Dutilh4, M. Eva Alonso5, Elisa de la Calle-Mustienes3, Leonie Smeenk2, Tuula Rinne1, Lilian Parsaulian1, Emine Bolat1, Rasa Jurgelenaite4, Martijn A. Huynen4, Alexander Hoischen1, Joris A. Veltman1, Han G. Brunner1, Tony Roscioli1, Emily Oates6, Meredith Wilson6, Miguel Manzanares5, Jose Luis Gomez-Skarmeta3, Hendrik G. Stunnenberg2, Marion Lohrum2, Hans van Bokhoven1,7*, Huiqing Zhou1* 1 Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 2 Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands, 3 Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide, Consejo Superior de Investigaciones Científicas, Sevilla, Spain, 4 Centre for Molecular and Biomolecular Informatics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen -
Small and Big Hodgkin-Reed-Sternberg Cells Of
RESEARCH ARTICLE Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L- 1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other Benjamin Rengstl1☯, Sooji Kim1☯, Claudia DoÈ ring1, Christian Weiser1, Julia Bein1, Katrin Bankov1, Marco Herling2,3, Sebastian Newrzela1, Martin-Leo Hansmann1, 1 a1111111111 Sylvia Hartmann * a1111111111 1 Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany, 2 Laboratory of a1111111111 Lymphocyte Signaling and Oncoproteome, Department of Internal Medicine I, University of Cologne, a1111111111 Cologne, Germany, 3 Center for Integrated Oncology (CIO) KoÈln-Bonn, CECAD, and CMMC, University of a1111111111 Cologne, Cologne, Germany ☯ These authors contributed equally to this work. * [email protected] OPEN ACCESS Abstract Citation: Rengstl B, Kim S, DoÈring C, Weiser C, Bein J, Bankov K, et al. (2017) Small and big The hallmark of classical Hodgkin lymphoma (cHL) is the presence of giant, mostly multinu- Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack cleated Hodgkin-Reed-Sternberg (HRS) cells. Whereas it has recently been shown that consistent differences in gene expression profiles giant HRS cells evolve from small Hodgkin cells by incomplete cytokinesis and re-fusion of and are capable to reconstitute each other. PLoS tethered sister cells, it remains unsolved why this phenomenon particularly takes place in ONE 12(5): e0177378. https://doi.org/10.1371/ this lymphoma and what the differences between these cell types of variable sizes are. The journal.pone.0177378 aim of the present study was to characterize microdissected small and giant HRS cells by Editor: Francesco Bertolini, European Institute of gene expression profiling and to assess differences of clonal growth behavior as well as sus- Oncology, ITALY ceptibility toward cytotoxic intervention between these different cell types to provide more Received: August 31, 2016 insight into their distinct cellular potential. -
A Truncating SHFM1DSS1 Germline Mutation in a Familial Breast Cancer Case: the List of Breast Cancer Susceptibility Genes Is Getting Longer
Central JSM Clinical Oncology and Research Research Article *Corresponding author Barbara Pasini, Medical Genetics Unit, AOU Città della Salute e della Scienza di Torino, Turin, Italy, Tel: 39-11- DSS1 6336681; Fax: 39-11-6335181; Email: A Truncating SHFM1 Germline Submitted: 28 July 2017 Mutation in a Familial Breast Accepted: 09 August 2017 Published: 11 August 2017 Cancer Case: the List of Breast Copyright © 2017 Pasini et al. Cancer Susceptibility Genes is OPEN ACCESS Keywords • Breast cancer Getting Longer • SHFM1 Francesca Vignolo Lutati1, Cecilia Bracco1,2,3, Anna Allavena1, • DSS1 • BRCA1 1 1,3 1 Paola Ogliara , Guido C. Casalis Cavalchini , Giorgia Mandrile , • BRCA2 Daniela F. Giachino3, and Barbara Pasini1,2,3* 1Medical Genetics Unit, San Luigi University Hospital, Italy 2Department of Medical Sciences, University of Turin, Italy 3Fondazione del Piemonte per l’Oncologia-IRCCS, Italy Abstract Although approximately 20% of breast cancer cases have a positive family history for the disease, less than 25% of familial cases carry an identified germline mutation in the “high risk” susceptibility genes, BRCA1, BRCA2 and TP53, or in the so called “moderate penetrance” susceptibility genes such as ATM, CHEK2, PALB2, SLX4, BRIP1, BARD1, MRE11A, RAD50 and NBN. These genes are involved in pathways related to DNA repair thus suggesting that a failure in maintaining genome integrity can increase breast cancer risk. Moreover, tumours with impaired DNA repair through homologous recombination as those occurring in BRCA1 or BRCA2 mutation carriers seem particularly sensitive to PARP inhibitors thus underlining the need of a better knowledge of the mechanisms promoting cancer development. With the aim to identify additional breast/ovarian cancer susceptibility genes belonging to the homologous recombination pathway, we focus our attention on SHFM1DSS1, a three exons gene on chromosome 7q encoding a highly conserved protein interacting with the longest region of evolutionary conservation of BRCA2. -
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis
University of Dundee The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis Mátyási, Barbara; Farkas, Zsolt; Kopper, László; Sebestyén, Anna; Boissan, Mathieu; Mehta, Anil Published in: Pathology and Oncology Research DOI: 10.1007/s12253-020-00797-0 Publication date: 2020 Licence: CC BY Document Version Publisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA): Mátyási, B., Farkas, Z., Kopper, L., Sebestyén, A., Boissan, M., Mehta, A., & Takács-Vellai, K. (2020). The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis. Pathology and Oncology Research, 26(1), 49-61. https://doi.org/10.1007/s12253-020-00797-0 General rights Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain. • You may freely distribute the URL identifying the publication in the public portal. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your -
Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7). -
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................ -
Transcriptional Recapitulation and Subversion Of
Open Access Research2007KaiseretVolume al. 8, Issue 7, Article R131 Transcriptional recapitulation and subversion of embryonic colon comment development by mouse colon tumor models and human colon cancer Sergio Kaiser¤*, Young-Kyu Park¤†, Jeffrey L Franklin†, Richard B Halberg‡, Ming Yu§, Walter J Jessen*, Johannes Freudenberg*, Xiaodi Chen‡, Kevin Haigis¶, Anil G Jegga*, Sue Kong*, Bhuvaneswari Sakthivel*, Huan Xu*, Timothy Reichling¥, Mohammad Azhar#, Gregory P Boivin**, reviews Reade B Roberts§, Anika C Bissahoyo§, Fausto Gonzales††, Greg C Bloom††, Steven Eschrich††, Scott L Carter‡‡, Jeremy E Aronow*, John Kleimeyer*, Michael Kleimeyer*, Vivek Ramaswamy*, Stephen H Settle†, Braden Boone†, Shawn Levy†, Jonathan M Graff§§, Thomas Doetschman#, Joanna Groden¥, William F Dove‡, David W Threadgill§, Timothy J Yeatman††, reports Robert J Coffey Jr† and Bruce J Aronow* Addresses: *Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. †Departments of Medicine, and Cell and Developmental Biology, Vanderbilt University and Department of Veterans Affairs Medical Center, Nashville, TN 37232, USA. ‡McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706, USA. §Department of Genetics and Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. ¶Molecular Pathology Unit and Center for Cancer Research, Massachusetts deposited research General Hospital, Charlestown, MA 02129, USA. ¥Division of Human Cancer Genetics, The Ohio State University College of Medicine, Columbus, Ohio 43210-2207, USA. #Institute for Collaborative BioResearch, University of Arizona, Tucson, AZ 85721-0036, USA. **University of Cincinnati, Department of Pathology and Laboratory Medicine, Cincinnati, OH 45267, USA. ††H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. ‡‡Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, Massachusetts 02115, USA. -
Short Time-Series Expression Transcriptome Data Reveal the Gene Expression Patterns of Dairy Cow Mammary Gland As Milk Yield Decreased Process
G C A T T A C G G C A T genes Article Short Time-Series Expression Transcriptome Data Reveal the Gene Expression Patterns of Dairy Cow Mammary Gland as Milk Yield Decreased Process Yongliang Fan 1,2, Ziyin Han 1,2, Xubin Lu 1,2 , Abdelaziz Adam Idriss Arbab 1,2, Mudasir Nazar 1,2, Yi Yang 3 and Zhangping Yang 1,2,* 1 College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China; [email protected] (Y.F.); [email protected] (Z.H.); [email protected] (X.L.); [email protected] (A.A.I.A.); [email protected] (M.N.) 2 Joint International Research Laboratory of Agriculture & Agri-Product Safety, Ministry of Education, Yangzhou University, Yangzhou 225009, China 3 Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University College of Veterinary Medicine, Yangzhou 225009, China; [email protected] * Correspondence: [email protected]; Tel.: +86-0514-87979269 Abstract: The existing research on dairy cow mammary gland genes is extensive, but there have been few reports about dynamic changes in dairy cow mammary gland genes as milk yield decrease. For the first time, transcriptome analysis based on short time-series expression miner (STEM) and histological observations were performed using the Holstein dairy cow mammary gland to explore gene expression patterns in this process of decrease (at peak, mid-, and late lactation). Histological observations suggested that the number of mammary acinous cells at peak/mid-lactation was Citation: Fan, Y.; Han, Z.; Lu, X.; significantly higher than that at mid-/late lactation, and the lipid droplets area secreted by dairy Arbab, A.A.I.; Nazar, M.; Yang, Y.; cows was almost unaltered across the three stages of lactation (p > 0.05).